Outsourced Pharma Capacity Update: Large Molecule Drug Substance & Development (free virtual event)

Leading CDMOs share their current available capacity – and associated capabilities, facility locations, and timelines – to help you identify options for your development and manufacturing needs.

Dive into the biopharmaceutical realm, where the synthesis of biologically derived APIs encompasses cell line development, fermentation, and sophisticated purification techniques. The event will feature insights into process optimization and scale-up, which are crucial for meeting production demands without compromising quality. Discover the meticulous quality control practices that underpin the production of biopharmaceuticals, laying the groundwork for novel biologic therapies.

What can you expect? – Short, digestible presentations with live interaction to give you an inside look at the available capacity of industry suppliers. You will have the opportunity to ask questions of each CDMO to better understand if they can meet your needs – all from the convenience of your computer!

Please note that this event is for biopharma companies seeking available capacity to connect with CDMOs who have that capacity available. Attendance is open to the following:

Individuals working for a pharma or biotech company with an active therapeutic pipeline.
Industry consultants and capital investment firms.
CDMO sponsors of the event.